HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift ...

Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...

BEDFORD, Mass., May 11 Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical ...

NovaSure patients in study also used fewer pads and tampons, reported better menstrual-related quality of life and alleviation of PMS symptoms as compared to Minerva patients The pivotal study ...

--Smaller 6mm Diameter and Other Product Enhancements are Designed to Increase Patient Comfort and Improve Physician Ease-of-Use-- MARLBOROUGH, Massachusetts, Nov. 14, 2016 /PRNewswire/ --Hologic, Inc ...

MARLBOROUGH, Mass. — Hologic Inc. (Nasdaq: HOLX), a global leader in women’s health, has announced approval of the NovaSure ® V5 global endometrial ablation (GEA) device in Canada and Europe. This ...

Recently, Conceptus (NasdaqGS:CPTS - News) received an Approvable Letter from the US Food and Drug Administration (:FDA). The letter suggests compatibility between the company’s surgical permanent ...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...

BEDFORD, Mass., Nov. 19, 2014 /PRNewswire/ -- Hologic, Inc. , today announced the launch of the next-generation NovaSure 6mm global endometrial ablation (GEA) system. The NovaSure system is designed ...

“Since its launch over 20 years ago, we have constantly listened to our customers’ feedback, which has driven continuous design improvements for NovaSure,” said Jan Verstreken, Group President, ...